Michael Campbell, PhD

Title(s)Professor, Surgery
SchoolSchool of Medicine
Address2340 Sutter Street, #N321
San Francisco CA 94115
Phone415-476-8094
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer. Cell Rep Med. 2024 Nov 19; 5(11):101799. Campbell MJ, Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM, I-SPY2 Investigators, Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. PMID: 39510069; PMCID: PMC11604542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women. mSystems. 2024 Nov 19; 9(11):e0123724. McCune E, Sharma A, Johnson B, O'Meara T, Theiner S, Campos M, Heditsian D, Brain S, Gilbert JA, Esserman L, Campbell MJ. PMID: 39470189; PMCID: PMC11575313.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ. NPJ Breast Cancer. 2024 Aug 04; 10(1):71. Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A. PMID: 39098868; PMCID: PMC11298531.
      View in: PubMed   Mentions:
    4. Tumor microenvironmental determinants of high-risk DCIS progression. Res Sq. 2024 May 09. Borowsky A, Glencer A, Ramalingam K, Schindler N, Mori H, Ghule P, Lee K, Nachmanson D, Officer A, Harismendy O, Stein J, Stein G, Evans M, Weaver D, Yau C, Hirst G, Campbell M, Esserman L. PMID: 38766192; PMCID: PMC11100907.
      View in: PubMed   Mentions:
    5. Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell Rep Med. 2023 12 19; 4(12):101312. Gallagher RI, Wulfkuhle J, Wolf DM, Brown-Swigart L, Yau C, O'Grady N, Basu A, Lu R, Campbell MJ, Magbanua MJ, Coppé JP, I-SPY 2 Investigators, Asare SM, Sit L, Matthews JB, Perlmutter J, Hylton N, Liu MC, Symmans WF, Rugo HS, Isaacs C, DeMichele AM, Yee D, Pohlmann PR, Hirst GL, Esserman LJ, van 't Veer LJ, Petricoin EF. PMID: 38086377; PMCID: PMC10772394.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 12 01; 6(12):e2349646. Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. PMID: 38153734; PMCID: PMC10755617.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    7. B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer. Breast Cancer Res. 2023 10 04; 25(1):117. Steenbruggen TG, Wolf DM, Campbell MJ, Sanders J, Cornelissen S, Thijssen B, Salgado RA, Yau C, O-Grady N, Basu A, Bhaskaran R, Mittempergher L, Hirst GL, Coppe JP, Kok M, Sonke GS, van 't Veer LJ, Horlings HM. PMID: 37794508; PMCID: PMC10552219.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Adrenal Neoplasms: Lessons from Adrenal Multidisciplinary Tumor Boards. Radiographics. 2023 07; 43(7):e220191. Chung R, Garratt J, Remer EM, Navin P, Blake MA, Taffel MT, Hackett CE, Sharbidre KG, Tu W, Low G, Bara M, Carney BW, Corwin MT, Campbell MJ, Campbell MJ, Lee JT, Lee CY, Dueber JC, Shehata MA, Caoili EM, Schieda N, Elsayes KM. PMID: 37347698.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort. Cancer Res Commun. 2022 12; 2(12):1579-1589. Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky AD, Esserman LJ. PMID: 36970720; PMCID: PMC10035518.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19. Surgery. 2023 Jan; 173(1):93-100. Collins RA, DiGennaro C, Beninato T, Gartland RM, Chaves N, Broekhuis JM, Reddy L, Lee J, Deimiller A, Alterio MM, Campbell MJ, Campbell MJ, Lee YJ, Khilnani TK, Stewart LA, O'Brien MA, Alvarado MVY, Zheng F, McAneny D, Liou R, McManus C, Dream SY, Wang TS, Yen TW, Alhefdhi A, Finnerty BM, Fahey TJ, Graves CE, Laird AM, Nehs MA, Drake FT, Lee JA, McHenry CR, James BC, Pasieka JL, Kuo JH, Lubitz CC. PMID: 36210185; PMCID: PMC9420726.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. NPJ Breast Cancer. 2021 May 25; 7(1):59. Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ, Campbell MJ. PMID: 34035311; PMCID: PMC8149838.
      View in: PubMed   Mentions: 5  
    12. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence. J Mammary Gland Biol Neoplasia. 2020 12; 25(4):417-432. Mori H, Bolen J, Schuetter L, Massion P, Hoyt CC, VandenBerg S, Esserman L, Borowsky AD, Campbell MJ, Campbell MJ. PMID: 33590360; PMCID: PMC7960613.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    13. Germline genetic contribution to the immune landscape of cancer. Immunity. 2021 02 09; 54(2):367-386.e8. Sayaman RW, Saad M, Thorsson V, Hu D, Hendrickx W, Roelands J, Porta-Pardo E, Mokrab Y, Farshidfar F, Kirchhoff T, Sweis RF, Bathe OF, Heimann C, Campbell MJ, Campbell MJ, Stretch C, Huntsman S, Graff RE, Syed N, Radvanyi L, Shelley S, Wolf D, Marincola FM, Ceccarelli M, Galon J, Ziv E, Bedognetti D. PMID: 33567262; PMCID: PMC8414660.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    14. Adrenal Tumors Found During Staging and Surveillance for Colorectal Cancer: Benign Incidentalomas or Metastatic Disease? World J Surg. 2020 07; 44(7):2282-2287. Yanagisawa M, Malik DG, Loehfelm TW, Fananapazir G, Corwin MT, Campbell MJ, Campbell MJ. PMID: 32206857.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer. Breast Cancer Res Treat. 2017 01; 161(1):41-50. Amara D, Wolf DM, van 't Veer L, Esserman L, Campbell M, Yau C. PMID: 27815749.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    16. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2017 01; 161(1):17-28. Campbell MJ, Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. PMID: 27785654; PMCID: PMC5225037.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    17. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ. PMID: 24205370; PMCID: PMC3812150.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    18. Biology of breast cancer in Nigerian women: a pilot study. Ann Afr Med. 2012 Jul-Sep; 11(3):169-75. Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ. PMID: 22684136.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    19. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer. Ann Surg Oncol. 2012 Nov; 19(12):3979-86. Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Campbell MJ, Esserman LJ. PMID: 22622474.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    20. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011 Nov; 130(2):635-44. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Campbell MJ, Esserman LJ. PMID: 21717106.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    21. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn. 2011 Jan; 11(1):91-100. Mukhtar RA, Nseyo O, Campbell MJ, Campbell MJ, Esserman LJ. PMID: 21171924.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    22. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat. 2011 Aug; 128(3):703-711. Campbell MJ, Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ. PMID: 20842526; PMCID: PMC4657137.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCells
    23. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44. Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. PMID: 19728082; PMCID: PMC4087110.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    24. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. J Cell Biochem. 2008 Feb 01; 103(2):624-35. Zavodovskaya M, Campbell MJ, Campbell MJ, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID. PMID: 17562544.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    25. Breast cancer growth prevention by statins. Cancer Res. 2006 Sep 01; 66(17):8707-14. Campbell MJ, Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. PMID: 16951186.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansCells
    26. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice. Cancer Gene Ther. 2006 Nov; 13(11):1002-10. Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM. PMID: 16841083.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    27. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol. 2006 May 01; 24(13):2127; author reply 2127-8. Kumar AS, Campbell M, Benz CC, Esserman LJ. PMID: 16648516.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    28. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther. 2006 Apr; 5(4):1079-86. Gable KL, Maddux BA, Penaranda C, Zavodovskaya M, Campbell MJ, Campbell MJ, Lobo M, Robinson L, Schow S, Kerner JA, Goldfine ID, Youngren JF. PMID: 16648580.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    29. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat. 2005 Nov; 94(1):37-46. Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID. PMID: 16142439.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    30. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res. 2005 Jul; 19(7):649-51. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ, Campbell MJ. PMID: 16161030.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    31. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005 May; 91(2):163-71. Campbell MJ, Campbell MJ, Scott J, Maecker HT, Park JW, Esserman LJ. PMID: 15868444.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    32. Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res. 2004 Nov 01; 64(21):7732-9. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, Lee JD. PMID: 15520177.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    33. Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol. 2004 Aug; 93(2-3):381-4. Shoemaker M, Cohen I, Campbell M. PMID: 15234781.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    34. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res. 2002 Nov-Dec; 22(6C):3843-52. Campbell MJ, Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D. PMID: 12553004.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    35. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim. 2002 Jun; 38(6):326-33. Campbell MJ, Campbell MJ, Wollish WS, Lobo M, Esserman LJ. PMID: 12513120.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    36. Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene. 2000 Dec 07; 19(52):5982-7. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G. PMID: 11146549.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    37. Biological therapies for breast carcinoma: concepts for improvement in survival. Semin Oncol. 1999 Aug; 26(4 Suppl 12):28-40. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM. PMID: 10482192.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    38. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Cancer Immunol Immunother. 1999 Feb; 47(6):337-42. Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell MJ. PMID: 10203064; PMCID: PMC11037317.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    39. Clinical trials of idiotype-specific vaccine in B-cell lymphomas. Ann N Y Acad Sci. 1993 Aug 12; 690:385-7. Hsu FJ, Kwak L, Campbell M, Liles T, Czerwinski D, Hart S, Syrengelas A, Miller R, Levy R. PMID: 8368764.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    40. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med. 1992 Oct 22; 327(17):1209-15. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R. PMID: 1406793.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    41. Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction. Cancer Res. 1992 Aug 01; 52(15):4117-20. Kwak LW, Campbell MJ, Levy R. PMID: 1638524.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    42. Interleukin 3 is a growth factor for human follicular B cell lymphoma. J Exp Med. 1992 Feb 01; 175(2):371-6. Clayberger C, Luna-Fineman S, Lee JE, Pillai A, Campbell M, Levy R, Krensky AM. PMID: 1732410; PMCID: PMC2119105.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    43. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb; 29(2):193-203. Campbell MJ, Zelenetz AD, Levy S, Levy R. PMID: 1542297.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    44. Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy. Blood. 1991 Nov 15; 78(10):2768-72. Kwak LW, Campbell MJ, Zelenetz AD, Levy R. PMID: 1824269.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    45. Ig VH gene expression among human follicular lymphomas. Blood. 1991 Sep 15; 78(6):1561-8. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. PMID: 1909196.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    46. Follicular lymphoma: a model of lymphoid tumor progression in man. Ann Oncol. 1991 Feb; 2 Suppl 2:115-22. Zelenetz AD, Campbell MJ, Bahler DW, Takahashi S, Oren R, Esserman L, Umetsu DT, Kwak LW, Maloney DG, Brown S, et al. PMID: 2049308.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    47. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Cancer Detect Prev. 1991; 15(4):323-5. Kwak LW, Campbell M, Levy R. PMID: 1794139.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    48. Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin. Blood. 1990 Dec 01; 76(11):2411-7. Kwak LW, Campbell MJ, Zelenetz AD, Levy R. PMID: 2257310.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCellsPHPublic Health
    49. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990 Aug 01; 145(3):1029-36. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. PMID: 2373859.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCellsPHPublic Health
    50. Idiotypic variation in a human B lymphoma cell line. J Immunol. 1990 Jan 15; 144(2):752-8. Berinstein N, Campbell MJ, Lam K, Carswell C, Levy S, Levy R. PMID: 2295809.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    51. Functional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line. J Exp Med. 1989 Jul 01; 170(1):1-13. Levy S, Campbell MJ, Levy R. PMID: 2501443; PMCID: PMC2189373.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    52. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor. Int Rev Immunol. 1989; 4(4):251-70. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. PMID: 2519929.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    53. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. J Immunol. 1988 Nov 01; 141(9):3227-33. Campbell MJ, Esserman L, Levy R. PMID: 3049819.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    54. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action. J Immunol. 1988 Oct 15; 141(8):2855-60. Basham TY, Race ER, Campbell MJ, Reid TR, Levy R, Merigan TC. PMID: 2971732.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    55. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants. J Immunol. 1988 Jul 01; 141(1):333-9. Starnes CO, Carroll WL, Campbell MJ, Houston LL, Apell G, Levy R. PMID: 3132505.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    56. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol. 1987 Oct 15; 139(8):2825-33. Campbell MJ, Carroll W, Kon S, Thielemans K, Rothbard JB, Levy S, Levy R. PMID: 3498771.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCellsPHPublic Health
    57. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood. 1987 Jan; 69(1):199-210. Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R. PMID: 2431729.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    58. Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies. J Immunol. 1986 Apr 15; 136(8):2983-8. Campbell M, Bieber M, Levy R, Teng NN. PMID: 3485677.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    59. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol. 1986 Feb 01; 136(3):1123-30. Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R. PMID: 3484499.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    Michael's Networks
    Concepts (299)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.